Fig. 1From: A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)Standard protocol items: recommendation for interventional trials (SPIRIT) figure demonstrating the study timeline for the randomized, double-blind trial of NI-03 for pain control among subjects with painful chronic pancreatitis. BPI, Brief Pain Inventory; PANQOLI, Pancreatitis Quality of Life Instrument; TID, three times per day; EKG, electrocardiogramBack to article page